CCL11 and neoplasm: Next, we established control and ATX-deficient tumors, sorted EpCAM+ tumor cells by fluorescence-activated cell sorting (FACS) and measured Ccl11 expression, which was higher in ATX-deficient PDAC cells (Fig. 5f).